{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:40:08Z","timestamp":1792107608531,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.josat.2023.209209","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T02:36:25Z","timestamp":1699238185000},"page":"209209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluation of opioid use disorder treatment outcomes in patients receiving split daily versus once daily dosing of buprenorphine-naloxone"],"prefix":"10.1016","volume":"156","author":[{"given":"Joshua B.","family":"Borris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Dowd-Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay A.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne A.","family":"Nesbit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fingerhood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalyn W.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.josat.2023.209209_bb0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/ajad.13267","article-title":"Outcomes associated with once-daily versus multiple-daily dosing of buprenorphine\/naloxone for opioid use disorder","volume":"31","author":"Allen","year":"2022","journal-title":"The American Journal on Addictions"},{"issue":"3","key":"10.1016\/j.josat.2023.209209_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: The foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"4","key":"10.1016\/j.josat.2023.209209_bb0015","doi-asserted-by":"crossref","first-page":"459.e1","DOI":"10.1016\/j.ajog.2017.06.029","article-title":"An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy","volume":"217","author":"Caritis","year":"2017","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1016\/j.josat.2023.209209_bb0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0091270005284192","article-title":"Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trials","volume":"46","author":"Ciraulo","year":"2006","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.josat.2023.209209_bb0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ADM.0000000000000457","article-title":"Buprenorphine pharmacology review: Update on transmucosal and long-acting formulations","volume":"13","author":"Coe","year":"2019","journal-title":"Journal of Addiction Medicine"},{"issue":"7","key":"10.1016\/j.josat.2023.209209_bb0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.18553\/jmcp.2012.18.7.527","article-title":"Dosing frequency and medication adherence in chronic disease","volume":"18","author":"Coleman","year":"2012","journal-title":"Journal of Managed Care Pharmacy: JMCP"},{"issue":"7","key":"10.1016\/j.josat.2023.209209_bb0035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","article-title":"Buprenorphine: Clinical pharmacokinetics in the treatment of opioid dependence","volume":"44","author":"Elkader","year":"2005","journal-title":"Clinical Pharmacokinetics"},{"issue":"8","key":"10.1016\/j.josat.2023.209209_bb0040","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s11606-020-05779-1","article-title":"Baseline factors associated with mortality in patients who engaged in buprenorphine treatment for opioid use disorder: A cohort study","volume":"35","author":"Fine","year":"2020","journal-title":"Journal of General Internal Medicine"},{"issue":"9","key":"10.1016\/j.josat.2023.209209_bb0045","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1080\/03007995.2018.1477747","article-title":"A systematic literature review comparing methods for the measurement of patient persistence and adherence","volume":"34","author":"Forbes","year":"2018","journal-title":"Current Medical Research and Opinion"},{"issue":"1","key":"10.1016\/j.josat.2023.209209_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopsych.2006.04.043","article-title":"Buprenorphine duration of action: Mu-opioid receptor availability and pharmacokinetic and behavioral indices","volume":"61","author":"Greenwald","year":"2007","journal-title":"Biological Psychiatry"},{"issue":"11","key":"10.1016\/j.josat.2023.209209_bb0055","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.npp.1300251","article-title":"Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers","volume":"28","author":"Greenwald","year":"2003","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"18","key":"10.1016\/j.josat.2023.209209_bb0060","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.josat.2023.209209_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108329","article-title":"Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings","volume":"126","author":"Krawczyk","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2023.209209_bb0070","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1360-0443.1998.93454910.x","article-title":"Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine","volume":"93","author":"Kuhlman","year":"1998","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.josat.2023.209209_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2023.209209_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/SAR.S150253","article-title":"Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder","volume":"9","author":"Ronquest","year":"2018","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"6","key":"10.1016\/j.josat.2023.209209_bb0085","first-page":"e22","article-title":"Effect of medication dosing frequency on adherence in chronic diseases","volume":"15","author":"Saini","year":"2009","journal-title":"The American Journal of Managed Care"},{"issue":"6","key":"10.1016\/j.josat.2023.209209_bb0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11606-011-1962-8","article-title":"Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care","volume":"27","author":"Schackman","year":"2012","journal-title":"Journal of General Internal Medicine"},{"issue":"4","key":"10.1016\/j.josat.2023.209209_bb0095","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.josat.2023.209209_bb0100","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"j1550","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.josat.2023.209209_bb0105","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/15622975.2011.561872","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence","volume":"12","author":"Soyka","year":"2011","journal-title":"The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry"},{"key":"10.1016\/j.josat.2023.209209_bb0110","series-title":"Suboxone [package insert]","year":"2019"},{"key":"10.1016\/j.josat.2023.209209_bb0115","series-title":"Key substance use and mental health indicators in the United States: Results from the 2021 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2022"},{"key":"10.1016\/j.josat.2023.209209_bb0120","series-title":"Medications for opioid use disorder","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2021"},{"key":"10.1016\/j.josat.2023.209209_bb0125","series-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update","first-page":"1","volume":"14","year":"2020"},{"issue":"1","key":"10.1016\/j.josat.2023.209209_bb0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"Journal of Addictive Diseases"},{"issue":"4","key":"10.1016\/j.josat.2023.209209_bb0135","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jsat.2013.10.014","article-title":"Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patients","volume":"46","author":"Tkacz","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.josat.2023.209209_bb0140","first-page":"313","article-title":"Buprenorphine therapy for opioid use disorder","volume":"97","author":"Zoorob","year":"2018","journal-title":"American Family Physician"},{"key":"10.1016\/j.josat.2023.209209_bb0145","series-title":"Zubsolv [package insert]","year":"2021"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:51:37Z","timestamp":1757433097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":29,"alternative-id":["S2949875923002606"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209209","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of opioid use disorder treatment outcomes in patients receiving split daily versus once daily dosing of buprenorphine-naloxone","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209209"}}